BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36342054)

  • 1. Current status of transanal total mesorectal excision for rectal cancer and the expanding indications of the transanal approach for extended pelvic surgeries.
    Uehara K; Ogura A; Murata Y; Sando M; Mukai T; Aiba T; Yamamura T; Nakamura M
    Dig Endosc; 2023 Jan; 35(2):243-254. PubMed ID: 36342054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and functional outcomes after transanal total mesorectal excision for rectal cancer-results from the implementation period in Denmark.
    Bjoern MX; Clausen FB; Seiersen M; Bulut O; Bech-Knudsen F; Jansen JE; Gögenur I; Klein MF
    Int J Colorectal Dis; 2022 Sep; 37(9):1997-2011. PubMed ID: 35960389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma?
    Butterworth JW; Butterworth WA; Meyer J; Giacobino C; Buchs N; Ris F; Scarpinata R
    Tech Coloproctol; 2021 Nov; 25(11):1183-1198. PubMed ID: 34562160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of transanal total mesorectal excision in radical surgery for rectal cancer].
    He L; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):957-960. PubMed ID: 28836258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and narrow pelvis prolong the operative time in conventional laparoscopic rectal cancer surgery, but not in a two-team transanal total mesorectal excision approach.
    Hasegawa H; Matsuda T; Yamashita K; Sawada R; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
    Asian J Endosc Surg; 2023 Apr; 16(2):189-196. PubMed ID: 36195976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.
    Shin JK; Kim HC; Yun SH; Park YA; Cho YB; Huh JW; Lee WY
    Surg Endosc; 2021 Dec; 35(12):6998-7004. PubMed ID: 33523275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.
    Kagami S; Funahashi K; Koda T; Ushigome T; Kaneko T; Suzuki T; Miura Y; Nagashima Y; Yoshida K; Kurihara A
    World J Surg Oncol; 2022 Nov; 20(1):363. PubMed ID: 36376924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of a Transanal TME Platform to Enable a Distal TME Dissection En Bloc with Presacral Fascia and Pelvic Sidewall with Intraoperative Radiotherapy Delivery in a Locally Advanced Rectal Cancer: Advanced Application of taTME.
    Waters PS; Peacock O; Larach T; Lee JD; McCormick JJ; Chander S; Heriot AG; Warrier SK
    J Laparoendosc Adv Surg Tech A; 2020 Jan; 30(1):53-57. PubMed ID: 31721637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic total mesorectal excision or transanal total mesorectal excision meta-analysis.
    Chen MZ; Tay YK; Warrier SK; Heriot AG; Kong JC
    ANZ J Surg; 2021 Nov; 91(11):2269-2276. PubMed ID: 34553466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
    Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
    Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.
    Veltcamp Helbach M; Koedam TWA; Knol JJ; Diederik A; Spaargaren GJ; Bonjer HJ; Tuynman JB; Sietses C
    Surg Endosc; 2019 Jan; 33(1):94-102. PubMed ID: 29967990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.